Real-world digital biomarkers correlated with their clinical counterparts in MS-DETECT
At the CHARCOT Congress held in November 2025 in Baveno, Italy, we highlighted the importance of remote symptom assessment with MSCopilot®. Our study demonstrates a correlation between our medical device and standard clinical scores in patients with multiple sclerosis (MS). The device allows essential disease functions to be measured at home. In addition, its overall score correlates significantly with the MSFC-4 (the Multiple Sclerosis Functional Composite with its 4 Components), highlighting its potential as a tool for monitoring MS in real-life conditions.
English 
French